Cytokinetics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. 

CEO
Robert I. Blum
CEORobert I. Blum
Employees
253
Employees253
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
1997
Founded1997
Employees
253
Employees253

CYTK Key Statistics

Market cap
4.69B
Market cap4.69B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
$51.67
High today$51.67
Low today
$47.86
Low today$47.86
Open price
$51.67
Open price$51.67
Volume
200.13K
Volume200.13K
52 Week high
$55.80
52 Week high$55.80
52 Week low
$29.26
52 Week low$29.26

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

CYTK Earnings

-$1.02
-$0.68
-$0.34
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 2, After Hours
ActualExpected Nov 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.